Dr. Craig Kenesky is an associate in the New York office of Wilson Sonsini Goodrich & Rosati. Craig applies his background in synthetic organic, medicinal, peptide, bioorganic, and computational chemistry to the prosecution of domestic and foreign patent applications, as well as due diligence, freedom to operate, portfolio development strategy, opinions, and IP counseling. Craig represents clients in numerous technology-focused industries, including the chemical, pharmaceutical, biotechnology, nanotechnology, diagnostic, neutriceutical, healthcare, process and manufacturing, energy, clean technology, biofuel, genomics, software, information technology, bioinformatics, scientific instrument, personalized medicine, and medical device sectors.
He performs pre-transaction due diligence on behalf of both technology companies and venture capital groups, and he develops non-infringement and invalidity strategies for generic pharmaceutical companies. Craig teaches a class at Weill Cornell Medical College. The class covers the business strategies and decisions involved in the founding and early-stage management of a fundable and successful biotech start-up.
Craig’s doctoral research at the University of Pennsylvania focused on the total synthesis of architecturally complex anti-cancer natural products, inhibitors of HIV-1 protease, carbohydrate drugs, peptide-like biomaterials, and the computational and biochemical investigation of tubulin-drug interactions leading to cancer cell death. He also held a fellowship at Columbia University, where he developed artificial enzymes and synthetic organic nanowires.
- J.D., Rutgers University, Newark
- Fellowship, Bio-Organic Chemistry, Columbia University
- Ph.D., Organic Chemistry, University of Pennsylvania
- B.A., Chemistry, The Johns Hopkins University (Early Graduation)
- State Bar of New York
- U.S. Patent and Trademark Office
Rate : $$$